Status:
COMPLETED
Remifentanil and Atropine for Intubation in Neonates
Lead Sponsor:
King Saud University
Collaborating Sponsors:
McMaster University
Conditions:
Endotracheal Intubation
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The investigators hypothesize that the use of a combination of Atropine and Remifentanil will safely facilitate non emergent intubation procedure as effectively as the protocol of Atropine, Fentanyl, ...
Eligibility Criteria
Inclusion
- Hemodynamically stable neonates of any gestational age admitted to the Neonatal Intensive Care Unit at McMaster Children's Hospital requiring an elective endotracheal intubation was anticipated.
Exclusion
- Urgent intubations
- Cyanotic congenital heart lesions
- Anticipated difficult airway
- Concurrent or recently administered (within 3 hours of the procedure) intravenous opioid infusions
- Pre-existing hyperkalemia
- Family history of malignant hyperthermia
- Prior enrollment
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00815048
Start Date
January 1 2006
End Date
February 1 2008
Last Update
December 29 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McMaster University NICU
Hamilton, Ontario, Canada, L8S 4J9